Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Abstract Text:

Juan Madoz-Gúrpide,Rork Kuick,Hong Wang,David E Misek,Sam M Hanash,Juan ,Rork Kuick,Hong Wang,David E Misek,Sam M Hanash,

The identification of biomarkers (both molecules and profiles) in patient sera offers enormous interest for the diagnosis of cancers. In this context, the detection of antibodies to tumor cell autologous antigens possesses great potential. The humoral immune response represents a form of biological amplification of signals that are otherwise weak because of very low concentrations of antigen, especially in the early stages of cancers. Herein we present the use of integral microarrays spotted with tumor-derived proteins to investigate the antibody repertoire in the sera of lung cancer patients and controls. The use of two-dimensional liquid chromatography allowed us to separate proteins from the lung adenocarcinoma cell line A549 into 1760 fractions, which were printed in duplicate, along with various controls, onto nitrocellulose coated slides. The sensitivity and specificity of the microarrays to detect singular antibodies in fluids were first validated through the recognition of fractions containing a lung marker antigen by antibody probing. Twenty fractions were initially selected as highly reactive against the anti-PGP9.5 antibody, and subsequent mass spectrometry analyses confirmed the identity of PGP9.5 protein in four of them. As a result, the importance of neighboring fractions in microarray detection was revealed due to the spreading of proteins during the separation process. Next, the microarrays were individually incubated with 14 serum samples from patients with lung cancer patients, 14 sera from colon cancer patients, and 14 control sera from normal subjects. The reactivity of the selected fractions was analyzed, and the level of immunoglobulin bound to each fraction by each serum sample was quantified. Eight of the 20 fractions offered p values < 0.01 and were recognized by an average of four reacting patients, whereas no serum from normal individuals was positive for those fractions. Protein microarrays from tumor-derived fractions hold the diagnostic potential of uncovering antigens that induce an immune response in patients with certain types of cancers.

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Publishing Authors By Initials

J Madoz-Gúrpide,R Kuick,H Wang,DE Misek,SM Hanash,J ,R Kuick,H Wang,DE Misek,SM Hanash,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Molecular & cellular proteomics : MCP

VOLUME: 7

Page Numbers: 268-81

Journal Abbreviation: Mol. Cell Proteomics

ISSN: 1535-9476

DAY: 4

MONTH: 10

YEAR: 2007

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101125647

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.

AFFILIATION: Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Mol Cell Proteomics

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response Related Publications

• A mouse plasma peptide atlas as a resource for disease proteomics.
• A mouse to human search for plasma proteome changes associated with pancreatic tumor development.
• Book Review: Principles and practices of Genito-Urinary Oncology.
• Book review: Campbell's urology, 7th edition. (3 volume set).
• Co-amplification of a novel gene, NAG, with the N-myc gene in neuroblastoma.
• Crural tunica albuginea autograft for corporoplasty: an experimental animal study of hemodynamic, histopathological, and molecular effects in the long term.
• DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes.
• GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas.
• High yield of restriction fragment length polymorphisms in two-dimensional separations of human genomic DNA.
• ICF, an immunodeficiency syndrome: DNA methyltransferase 3B involvement, chromosome anomalies, and gene dysregulation.
• Identification of 14-3-3 theta as an antigen that induces a humoral response in lung cancer.
• Increased throughput and reduced carryover of mass spectrometry-based proteomics using a high-efficiency nonsplit nanoflow parallel dual-column capillary HPLC system.
• Integral protein microarrays for the identification of lung cancer antigens in sera that induce a humoral immune response.
• Isoform Analysis of LC-MS/MS Data from Multidimensional Fractionation of the Serum Proteome.
• Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells.
• Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.
• Studies of the inheritance of human ribosomal DNA variants detected in two-dimensional separations of genomic restriction fragments.
• The clinical spectrum of phaeochromocytoma: analysis of 115 patients.
• Two-dimensional separation and cloning of chromosome 1 NotI-EcoRV-derived genomic fragments.